Allianz's Pimco Buyout Caps a €2bn Shopping Spree — Just as Wall Street Splits on the Share Price
Published on 08/15/2026 at 12:51 | Redaktion boerse-global.de
The Munich insurer's late-July acquisition blitz has reshaped its asset-management arm, its Asian footprint and its boardroom in one stroke. But the market's verdict on the shares is now split down the middle, with two of Wall Street's biggest houses drawing opposite conclusions from the same set of numbers.
Allianz raised its stake in US bond giant Pimco from 90.6 percent to at least 95 percent on July 31, paying a minimum of €1.4 billion for the increment. The move terminates an 18-year-old employee ownership scheme under which current and former Pimco managers held roughly 9.4 percent of the firm through so-called "M Units." Jefferies' analyst dubbed the top-up a "pleasant surprise," pointing to an attractive price for one of the industry's highest-quality asset managers. Pimco had just posted strong second-quarter inflows of €31.7 billion from third-party investors, mostly into fixed-income strategies.
A Regional Pivot in Asia
The Pimco transaction was the centrepiece of a cluster of deals unveiled in late July. The largest is the planned acquisition of HSBC Life Singapore for around €2 billion, tied to a long-term distribution partnership with HSBC and slated to close in the first half of 2027. In a separate move, fund subsidiary AllianzGI agreed to buy UOB Asset Management from United Overseas Bank for S$555 million — roughly €376 million — taking over a unit that manages €28 billion across eight Asian markets, subject to regulatory approval and expected to complete in 2027.
Smaller purchases round out the flurry: Portuguese insurer Caravela for about €150 million and the travel-insurance business of Nib Group in Australia and New Zealand for up to A$50 million.
Should investors sell immediately? Or is it worth buying Allianz?
Management Reshuffle Runs in Parallel
The external expansion comes with an internal reorganisation. GĂĽnther Thallinger, the board member responsible for Global Health, Investment Management and Sustainability, departs at year-end, shrinking the executive board from nine to eight seats. Tomas Kunzmann, who has led Allianz Partners since July 2022, steps up on January 1, 2027 to take charge of the Asia-Pacific/India region along with Global Health and Sustainability. Andreas Wimmer assumes responsibility for Investment Management, tasked with tighter integration of capital-markets, investment and steering functions.
Two Houses, Two Verdicts
The share price has responded to the dealmaking and the record operating results behind it — but the analyst community is no longer speaking with one voice. On Friday, JPMorgan lifted its price target from €430 to €460, while Goldman Sachs raised its own to €465. The divergence lies in their ratings: Goldman reaffirmed "Buy," seeing roughly 6 percent upside, while JPMorgan's Kamran M. Hossain cut the stock to "Neutral" even as he raised his operating-profit forecasts through 2028.
Both houses were reacting to the same half-year report published earlier in the week, in which operating profit rose 8.6 percent. The split reflects a fundamental disagreement about valuation rather than about operational performance: Goldman still sees headroom, while JPMorgan effectively argues the shares are fairly priced.
Technical Signals Add Caution
The stock closed Friday at €441.60, up 0.7 percent on the day and just 0.5 percent below its 52-week high of €443.80, set on August 6. The price now sits almost exactly between the two new price targets — a fact that sharpens the valuation debate. The 14-day relative strength index stands at 70.2, flagging overbought conditions. The shares have gained roughly 13 percent since the start of the year and 17 percent over twelve months, trading 15 percent above their 200-day moving average.
JPMorgan's August 14 note, which cited higher operating-profit projections for 2026 through 2028, left the rating unchanged at "Neutral" — a signal that even the deal spree and the strong run have not erased caution on valuation. Allianz is scheduled to publish third-quarter results on November 12.
Ad
Allianz Stock: New Analysis - 15 August
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
